Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in Stroke


Phase 4 Results N/A

Summary of Purpose

This study, E-COMPASSII is a phase IV clinical trial designed as a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. This study will enroll 80 subacute stroke patients with severe motor involvement. Primary objective is to demonstrate the efficacy of porcine brain peptide to improve motor recovery measured by the improvement ratio of Fugl-Meyer assessment ((score of FMA after 3...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 May 2016.

1 Jan 2016 4 Mar 2016 1 Aug 2017 1 Aug 2017 1 May 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment